Efforts to curb the transmission of contracting COVID-19 by handwashing has lessened according to an annual survey from Bradley Corp.
Episode 54
Editor Sydny Shepard goes over the newest information from the Chemical Safety Board on the gas leak at a Georgia poultry plant that killed 6 people.
Episode 53
On this Safety Speak episode of the podcast, Editor Sydny Shepard discusses the new OSHA guidance on COVID-19, the Center for Construction Research and Training’s new bulletin on nonfatal injury trends in the construction industry as well as news and studies surrounding transportation safety.
Episode 52
In this episode, listeners will hear about a new partnership between EPA and OSHA, Virginia's new permanent COVID-19 workplace safety standards and when industrial workers will be able to get the coronavirus vaccine.
Episode 48
Editor Sydny Shepard discusses the a new FAQ set up for those who have questions about the expired FFCRA, OSHA's impended deadlines for your Form 300A and updates on the vaccination rollout in the U.S.
Episode 46
In this Safety Speak mini episode of the podcast, Editor Sydny Shepard discusses ISO/PAS 45005: General guidelines for safe working during the COVID-19 pandemic, a new study on telecommuting and BLS data that shows workplace fatalities are at their highest since 2007.
An FDA panel voted 17–4 to give emergency use authorization to the Pfizer vaccine.
The FDA has approved an at-home test that can detect the presence of both coronavirus and the flu.
Britain is set to begin administering the first doses of the Pfizer vaccine next week.
Choices for Biden’s health team slots include Dr. Vivek Murphy, who served as surgeon general under President Obama.
Episode 43
In this episode of the podcast, listen in as Editor Sydny Shepard discusses Cal/OSHA's new emergency regulations to protect against COVID-19 as well as the CDC and FDA's plan on how a Coronavirus vaccine could be distributed in the United States.
The Department of Defense released photos of the vaccination kits and cards that will be part of the coronavirus vaccination process.
Moderna applied for FDA authorization for its vaccine, which is reportedly 100% effective at preventing serious cases of coronavirus, on Monday.
Research collected from recovered coronavirus patients suggests long term immunity to the virus is possible.
The first at-home COVID-19 test will soon be available for $50.
Moderna Inc. claims that its COVID-19 vaccine is 94.5% effective—a higher rate than Pfizer’s vaccine.
Employees that are working in person during the pandemic should be working in offices with adequate ventilation to minimize their risk of infection.
The CDC confirms that wearing a cloth mask can protect individuals from catching the coronavirus, not just those around them.
The antibody treatment is approved for administration in hospitals and other health care facilities.
OSHA compiled data from heavily cited establishments to create two new resources for employers to use during the current pandemic.